BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30863989)

  • 1. A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity.
    Diekjürgen D; Grainger DW
    Arch Toxicol; 2019 May; 93(5):1349-1364. PubMed ID: 30863989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model.
    Diekjürgen D; Grainger DW
    Pflugers Arch; 2018 Sep; 470(9):1311-1323. PubMed ID: 29744639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity and Kidney Transport Assessment on 3D Perfused Proximal Tubules.
    Vormann MK; Gijzen L; Hutter S; Boot L; Nicolas A; van den Heuvel A; Vriend J; Ng CP; Nieskens TTG; van Duinen V; de Wagenaar B; Masereeuw R; Suter-Dick L; Trietsch SJ; Wilmer M; Joore J; Vulto P; Lanz HL
    AAPS J; 2018 Aug; 20(5):90. PubMed ID: 30109442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid and ibandronate-induced nephrotoxicity in 2D and 3D proximal tubule cells derived from human and rat.
    Valencia LJ; Tseng M; Chu ML; Yu L; Adedeji AO; Kiyota T
    Toxicol Sci; 2024 Feb; 198(1):86-100. PubMed ID: 38059598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional transepithelial transport measurements to detect nephrotoxicity in vitro using the RPTEC/TERT1 cell line.
    Secker PF; Schlichenmaier N; Beilmann M; Deschl U; Dietrich DR
    Arch Toxicol; 2019 Jul; 93(7):1965-1978. PubMed ID: 31076804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity.
    Nieskens TTG; Persson M; Kelly EJ; Sjögren AK
    Drug Metab Dispos; 2020 Dec; 48(12):1303-1311. PubMed ID: 33020068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study.
    Suter-Dick L; Mauch L; Ramp D; Caj M; Vormann MK; Hutter S; Lanz HL; Vriend J; Masereeuw R; Wilmer MJ
    AAPS J; 2018 Jul; 20(5):86. PubMed ID: 30039346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model.
    Astashkina AI; Jones CF; Thiagarajan G; Kurtzeborn K; Ghandehari H; Brooks BD; Grainger DW
    Biomaterials; 2014 Aug; 35(24):6323-31. PubMed ID: 24814424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multi-parametric high content screening assay in ciPTEC-OAT1 to predict drug-induced nephrotoxicity during drug discovery.
    Sjögren AK; Breitholtz K; Ahlberg E; Milton L; Forsgard M; Persson M; Stahl SH; Wilmer MJ; Hornberg JJ
    Arch Toxicol; 2018 Oct; 92(10):3175-3190. PubMed ID: 30155723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds.
    Wu Y; Connors D; Barber L; Jayachandra S; Hanumegowda UM; Adams SP
    Toxicol In Vitro; 2009 Sep; 23(6):1170-8. PubMed ID: 19523510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro.
    Adler M; Ramm S; Hafner M; Muhlich JL; Gottwald EM; Weber E; Jaklic A; Ajay AK; Svoboda D; Auerbach S; Kelly EJ; Himmelfarb J; Vaidya VS
    J Am Soc Nephrol; 2016 Apr; 27(4):1015-28. PubMed ID: 26260164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods.
    Kandasamy K; Chuah JK; Su R; Huang P; Eng KG; Xiong S; Li Y; Chia CS; Loo LH; Zink D
    Sci Rep; 2015 Jul; 5():12337. PubMed ID: 26212763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based urine analysis in rats: prediction of proximal tubule kidney toxicity and phospholipidosis.
    Lienemann K; Plötz T; Pestel S
    J Pharmacol Toxicol Methods; 2008; 58(1):41-9. PubMed ID: 18606234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell- and biomarker-based assays for predicting nephrotoxicity.
    Huang JX; Blaskovich MA; Cooper MA
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1621-35. PubMed ID: 25382677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
    Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
    Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high content screening assay to predict human drug-induced liver injury during drug discovery.
    Persson M; Løye AF; Mow T; Hornberg JJ
    J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
    Im DS; Shin HJ; Yang KJ; Jung SY; Song HY; Hwang HS; Gil HW
    Toxicol Lett; 2017 Aug; 277():9-17. PubMed ID: 28549670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Proximal Tubule Tissues Recapitulate Key Aspects of Renal Physiology to Enable Nephrotoxicity Testing.
    King SM; Higgins JW; Nino CR; Smith TR; Paffenroth EH; Fairbairn CE; Docuyanan A; Shah VD; Chen AE; Presnell SC; Nguyen DG
    Front Physiol; 2017; 8():123. PubMed ID: 28337147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of MATE1 Inhibition and Cytotoxicity in Nephrotoxicity: Application for Safety Evaluation in Early Drug Discovery.
    Tohyama K; Chisaki I; Takai Y; Handa Y; Miyamoto M; Amano N
    Toxicol Sci; 2019 Jul; 170(1):223-233. PubMed ID: 31020312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPTEC/TERT1 cells form highly differentiated tubules when cultured in a 3D matrix.
    Secker PF; Luks L; Schlichenmaier N; Dietrich DR
    ALTEX; 2018; 35(2):223-234. PubMed ID: 29197217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.